Related Experiment Video
Updated: Jul 11, 2026
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Inflammatory mechanisms in diabetes: lessons from the beta-cell
H E Hohmeier1, V V Tran, G Chen
1Sarah W. Stedman Nutrition and Metabolism Center, Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Summary
Researchers developed strategies to protect pancreatic islet beta-cells from inflammatory damage, crucial for type I diabetes. Combining cytokine selection with bcl-2 gene overexpression significantly enhanced cell resistance to oxidative stress and cytotoxicity.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Inflammation, involving T-cells, macrophages, and cytokines like IL-1 beta, TNF-alpha, and IFN-gamma, drives pancreatic islet beta-cell destruction in type I diabetes.
- Oxidative stress and cytokine-induced cytotoxicity are key factors contributing to beta-cell failure.
Purpose of the Study:
- To summarize strategies developed for protecting pancreatic beta-cells from inflammatory and oxidative damage.
- To investigate mechanisms of beta-cell protection and their relevance to diabetes.
Main Methods:
- Development of cytokine-resistant cell lines through a cytokine selection strategy.
- Overexpression of the antiapoptotic gene bcl-2 in conjunction with cytokine selection.
- Evaluation of cell resistance to oxidative stress and cytokine-induced cytotoxicity.
Main Results:
- Cytokine selection yielded cell lines resistant to IL-1 beta + IFN-gamma.
- Combined cytokine selection and bcl-2 overexpression resulted in greater resistance than either method alone.
- Divergent mechanisms underlie the protection achieved in different model systems.
Conclusions:
- Strategies combining genetic modification (bcl-2 overexpression) and selection offer enhanced protection for beta-cells.
- Insights gained are potentially applicable to improving islet cell survival and function in both major forms of diabetes.
- Understanding these protective mechanisms is vital for therapeutic development in diabetes.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.